In patients with hyposmia, abnormal uptake on DAT-SPECT is a predictive factor of phenoconversion to PD, while in patients with iRBD, a DAT deficit identifies patients at short-term risk for synucleinopathy63,.64 This evidence concerns the gene SLC6A3 and Parkinson disease.